Praveen Rao, MD
Clinical Cardiac Electrophysiology · Dallas, TXNPI 1043448285
Payments from drug & device makers
Across 548 payments — averaging $246.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$87K
- Medtronic$32K
- Boston Scientific$7K
- Biosense Webster, Inc.$5K
- Medical Device Business Services, Inc.$2K
- AOP Health US, LLC$430
- plus $2K from 21 others
Across 1 payment — averaging $200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$200
What the payments were for
- Consulting fees$35,25253%
- Speaking & faculty fees$6,50010%
- Travel & lodging$10,87016%
- Food & beverage$14,36321%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 223 | $86,522 |
| Medtronic(2 entities) | 171 | $32,286 |
| Boston Scientific | 66 | $7,324 |
| Biosense Webster, Inc. | 20 | $5,256 |
| Medical Device Business Services, Inc. | 6 | $1,583 |
| AOP Health US, LLC | 1 | $430 |
| Atricure, Inc. | 7 | $376 |
| Novartis | 16 | $272 |
| ZOLL Respicardia, Inc. | 1 | $156 |
| Cardiva Medical, Inc. | 3 | $103 |
| Philips North America LLC | 6 | $95 |
| Innovation Technologies Inc | 2 | $84 |
| Novo Nordisk | 4 | $74 |
| Kestra Medical Technology Services, Inc. | 3 | $67 |
| Johnson & Johnson(2 entities) | 3 | $56 |
| GE HealthCare | 2 | $54 |
| E.r. Squibb & Sons, L.L.C. | 2 | $46 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Pfizer | 2 | $39 |
| Abiomed | 1 | $29 |
| Altathera Pharmaceuticals LLC | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $18 |
| Vital Connect, Inc | 1 | $17 |
| Cvrx, Inc. | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Itamar Medical Inc | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$5,614
- Carto 3$3,983
- Carto 3 System$3,938
- ENSITE$3,522
- ADVISOR$2,510
- EnSite Precision Cardiac Mapping System$2,267
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$2,147
- ENSITE PRECISION$1,488
- Rapiblyk$860
- Accent Pacemaker$780
- AVEIR$698
- Micra$331
- ASSURITY$164
- remede System$156
- ONYX FRONTIER$146
- SYMPLICITY G3$137
- ACCENT$127
- Capsure$114
- Fortify Assura$109
- AMPLATZER AMULET$106
How this compares
$135,002 in reported general payments places this provider in the 75th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 358 | $346,120 |
| XareltoRivaroxaban | 63 | $74,860 |
| EntrestoSacubitril/Valsartan | 12 | $11,676 |
| Flecainide Acetate | 129 | $6,221 |
| Dofetilide | 23 | $5,987 |
| Metoprolol Succinate | 153 | $2,203 |
| SotalolSotalol Hcl | 51 | $1,016 |
| Amiodarone Hcl | 70 | $955 |
| ClopidogrelClopidogrel Bisulfate | 62 | $787 |
| Potassium Chloride | 14 | $352 |
| Atorvastatin Calcium | 21 | $252 |
| Losartan Potassium | 15 | $144 |
| Metoprolol Tartrate | 22 | $130 |
| Carvedilol | 19 | $112 |
| Spironolactone | 16 | $102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $39 | $346,120358 claims |
| Johnson & JohnsonXarelto | $56 | $74,86063 claims |
| NovartisEntresto | $272 | $11,67612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Dallas
- Mustafa DohadwalaDallas$814K
- Charles LampeDallas$206K
- Russell CanhamDallas$184K
- Phi WiegnDallas$154K
- Adam ShapiraDallas$135K
- Brian leDallas$115K
- Andrea NataleAustin$7.8M
- George ManoukianShenandoah$3.2M
- Rodney HortonAustin$2.5M
- Stanislav WeinerLongview$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.